ABSTRACT Introduction: Helicobacter Pylori (H. Pylori) is a pathogen that infects about 50%
of the world's population and is known to be responsible for gastroduodenal diseases such …

Due to the high adaptability of Helicobacter pylori and the low targeting specificity of the
drugs normally used in pharmacological therapy, the strains are becoming increasingly …

Helicobacter pylori (H. pylori) is a recalcitrant pathogen, which can cause gastric disorders.
During the past decades, polypharmacy‐based regimens, such as triple and quadruple …

Introduction Helicobacter pylori is a widespread helical Gram-negative bacterium, which
causes a variety of stomach disorders, such as peptic ulcer, chronic atrophic gastritis, and …

The study demonstrates the feasibility of prolonging gastric residence time and release rate
of metronidazole (Mz) by preparing floating raft system (FRS) using ion-sensitive in situ gel …

This study aimed to design a hyaluronic acid-based targeted, mucoadhesive and
mucopenetrating drug delivery system encapsulating clarithromycin that would improve the …

Peptic ulcer disease (PUD) is one of the most prevalent gastro intestinal disorder which
often leads to painful sores in the stomach lining and intestinal bleeding. Untreated …

Gastric infections are mainly caused by Helicobacter pylori (H. pylori), a bacterium that
colonizes the gastric mucosa of over 50% of the world's population. Chronic H. pylori …

Helicobacter pylori (H. pylori) is a notorious, recalcitrant and silent germ, which can cause a
variety of debilitating stomach diseases, including gastric and duodenal ulcers and gastric …

Background Oral administration remains the most common mode of drug delivery. However,
orally administered bioactive compounds must first survive digestion and then be absorbed …